Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Therapeutic Antibodies seeks FDA approval for antivenom product

May 12, 1998

5-HT antibodies for treatment of alcoholism

May 8, 1998

Ro-19-4603 attenuates ethanol responding in alcohol-preferring rats

May 8, 1998

ImmuLogic evaluates cocaine vaccine in phase I

April 21, 1998

Nefiracetam: a potential treatment for PCP addiction?

April 2, 1998

Metadoxine is beneficial in alcoholic patients, even with continued alcohol consumption

March 26, 1998

Effects of EAA receptor antagonists on morphine tolerance and dependence

March 9, 1998

HBED proposed as alternative to deferoxamine as iron chelator

March 2, 1998

Nicotine inhaler launched in U.S.

March 2, 1998

The role of dopamine D2 receptor in alcohol intake suppression

Feb. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...